Literature DB >> 33787677

Is it Safe to Perform Elective Colorectal Surgical Procedures during the COVID-19 Pandemic? A Single Institution Experience with 103 Patients.

Lucas Faraco Sobrado1, Caio Sergio Rizkallah Nahas1, Carlos Frederico Sparapan Marques1, Guilherme Cutait de Castro Cotti1, Antônio Rocco Imperiale1, Pedro Averbach1, José Donizeti de Meira Júnior1, Natally Horvat1,2,3, Ulysses Ribeiro-Júnior1, Ivan Cecconello1, Sergio Carlos Nahas1.   

Abstract

OBJECTIVES: Since the outbreak of the novel coronavirus disease 2019 (COVID-19), all health services worldwide underwent profound changes, leading to the suspension of many elective surgeries. This study aimed to evaluate the safety of elective colorectal surgery during the pandemic.
METHODS: This was a retrospective, cross-sectional, single-center study. Patients who underwent elective colorectal surgery during the COVID-19 pandemic between March 10 and September 9, 2020, were included. Patient data on sex, age, diagnosis, types of procedures, hospital stay, mortality, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preoperative screening tests were recorded.
RESULTS: A total of 103 colorectal surgical procedures were planned, and 99 were performed. Four surgeries were postponed due to positive preoperative screening for SARS-CoV-2. Surgical procedures were performed for colorectal cancer (n=90) and inflammatory bowel disease (n=9). Laparoscopy was the approach of choice for 43 patients (43.4%), 53 (53.5%) procedures were open, and 3 (3%) procedures were robotic. Five patients developed COVID-19 in the postoperative period, and three of them died in the intensive care unit (n=3/5, 60% mortality). Two other patients died due to surgical complications unrelated to COVID-19 (n=2/94, 2.1% mortality) (p<0.01). Hospital stay was longer in patients with SARS-CoV-2 infection than in those without (38.4 versushttps://doi.org/10.3 days, respectively, p<0.01). Of the 99 patients who received surgical care during the pandemic, 94 were safely discharged (95%).
CONCLUSION: Our study demonstrated that elective colorectal surgical procedures may be safely performed during the pandemic; however, preoperative testing should be performed to reduce in-hospital infection rates, since the mortality rate due to SARS-CoV-2 in this setting is particularly high.

Entities:  

Mesh:

Year:  2021        PMID: 33787677      PMCID: PMC7955150          DOI: 10.6061/clinics/2021/e2507

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  13 in total

1.  Covid-19: all non-urgent elective surgery is suspended for at least three months in England.

Authors:  Gareth Iacobucci
Journal:  BMJ       Date:  2020-03-18

Review 2.  The risk of COVID-19 transmission by laparoscopic smoke may be lower than for laparotomy: a narrative review.

Authors:  Yoav Mintz; Alberto Arezzo; Luigi Boni; Ludovica Baldari; Elisa Cassinotti; Ronit Brodie; Selman Uranues; MinHua Zheng; Abe Fingerhut
Journal:  Surg Endosc       Date:  2020-05-26       Impact factor: 4.584

3.  COVID-19 in Brazil: "So what?"

Authors: 
Journal:  Lancet       Date:  2020-05-09       Impact factor: 79.321

Review 4.  Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance.

Authors:  Natália Sousa Freitas Queiroz; Luísa Leite Barros; Matheus Freitas Cardoso de Azevedo; Jane Oba; Carlos Walter Sobrado; Alexandre de Sousa Carlos; Luciane Reis Milani; Aytan Miranda Sipahi; Aderson Omar Mourão Cintra Damião
Journal:  Clinics (Sao Paulo)       Date:  2020-04-17       Impact factor: 2.365

5.  Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.

Authors:  Kunyu Yang; Yuhan Sheng; Chaolin Huang; Yang Jin; Nian Xiong; Ke Jiang; Hongda Lu; Jing Liu; Jiyuan Yang; Youhong Dong; Dongfeng Pan; Chengrong Shu; Jun Li; Jielin Wei; Yu Huang; Ling Peng; Mengjiao Wu; Ruiguang Zhang; Bian Wu; Yuhui Li; Liqiong Cai; Guiling Li; Tao Zhang; Gang Wu
Journal:  Lancet Oncol       Date:  2020-05-29       Impact factor: 41.316

6.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  INTESTINAL PERFORATION CAUSED BY COVID-19.

Authors:  Sergio Carlos Nahas; José Donizeti de Meira-JÚnior; Lucas Faraco Sobrado; Maurício Sorbello; Vanderlei Segatelli; Edson Abdala; Ulysses Ribeiro-JÚnior; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2020-11-20

8.  With adequate precautions colorectal cancer surgery can be safely continued during COVID-19 pandemic.

Authors:  Francesco Maria Carrano; Caterina Foppa; Michele Carvello; Antonino Spinelli
Journal:  Br J Surg       Date:  2020-07-31       Impact factor: 6.939

Review 9.  Laparoscopic surgery and coronavirus disease: What do we know now?

Authors:  Sergio Conti Ribeiro; Ana Luisa F Lauletta; Beatriz Couto Franco; Renata L Araujo Bezerra; Diana G B Salles Vanni; Edmund C Baracat
Journal:  Clinics (Sao Paulo)       Date:  2020-08-03       Impact factor: 2.365

10.  SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.

Authors:  Jing Yu; Wen Ouyang; Melvin L K Chua; Conghua Xie
Journal:  JAMA Oncol       Date:  2020-07-01       Impact factor: 31.777

View more
  7 in total

1.  RESULTS OF SURGICAL TREATMENT OF COLORECTAL CANCER, ELECTIVE AND EMERGENCY, IN PATIENTS WITH COVID-19.

Authors:  Sergio Carlos Nahas; José Donizeti de Meira Júnior; Caio Sergio Rizkallah Nahas; Lucas Faraco Sobrado; Rodrigo Ambar Pinto; Edson Abdala; Ulysses Ribeiro Junior; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2022-06-17

2.  Evaluating potential delays and outcomes of patients undergoing surgical resection for locally advanced and recurrent colorectal cancer during a pandemic.

Authors:  M A Javed; A Kohler; J Tiernan; A Quyn; P Sagar
Journal:  Ann R Coll Surg Engl       Date:  2022-02-08       Impact factor: 1.951

Review 3.  Robotic Abdominal Surgery and COVID-19: A Systematic Review of Published Literature and Peer-Reviewed Guidelines during the SARS-CoV-2 Pandemic.

Authors:  Christina A Fleming; Anna Fullard; Stefanie Croghan; Gianluca Pellino; Francesco Pata
Journal:  J Clin Med       Date:  2022-05-24       Impact factor: 4.964

4.  Impact of COVID-19 pandemic on the surgical treatment of gastric cancer.

Authors:  Amanda Juliani Arneiro; Marcus Fernando Kodama Pertille Ramos; Marina Alessandra Pereira; André Roncon Dias; Bruno Zilberstein; Ulysses Ribeiro Junior; Sergio Carlos Nahas
Journal:  Clinics (Sao Paulo)       Date:  2021-11-26       Impact factor: 2.365

Review 5.  Hospital acquired COVID-19 infections amongst patients before the rollout of COVID-19 vaccinations, a scoping review.

Authors:  Nobubelo K Ngandu; Tshiamo M Mmotsa; Reshmi Dassaye; Alice Thabetha; Willem Odendaal; Natasha Langdown; Duduzile Ndwandwe
Journal:  BMC Infect Dis       Date:  2022-02-10       Impact factor: 3.090

6.  The effect of the COVID-19 pandemic on the outcomes of surgically treated colorectal diseases: a retrospective cohort study.

Authors:  Gülten Çiçek Okuyan; Melih Yıldırım
Journal:  Ann Surg Treat Res       Date:  2022-08-05       Impact factor: 1.766

7.  Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis.

Authors:  Saad Alhumaid; Abbas Al Mutair; Jawad S Busubaih; Nourah Al Dossary; Murtadha Alsuliman; Sarah A Baltyour; Ibrahim Alissa; Hassan I Al Hassar; Noor A Al Aithan; Hani A Albassri; Suliman A AlOmran; Raed M ALGhazal; Ahmed Busbaih; Nasser A Alsalem; Waseem Alagnam; Mohammed Y Alyousef; Abdulaziz U Alseffay; Hussain A Al Aish; Ali Aldiaram; Hisham A Al Eissa; Murtadha A Alhumaid; Ali N Bukhamseen; Koblan M Al Mutared; Abdullah H Aljwisim; Abdullah M Twibah; Meteab M AlSaeed; Hussien A Alkhalaf; Fatemah M ALShakhs; Thoyaja Koritala; Jaffar A Al-Tawfiq; Kuldeep Dhama; Ali A Rabaan; Awad Al-Omari
Journal:  Infect Agent Cancer       Date:  2022-09-12       Impact factor: 3.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.